Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HORSE BLOOD CELLS IN ALSEVERS CITRATE/DEFIBRINATED

K-Number: K861817 · 1986-05-20

ApplicantHazleton Research Products, Inc.
Decision Date1986-05-20
Product CodeKIS
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

HORSE BLOOD CELLS IN ALSEVERS CITRATE/DEFIBRINATED is the device name listed in this FDA 510(k) record. The listed applicant is Hazleton Research Products, Inc.. It received FDA 510(k) clearance on 1986-05-20 under 510(k) number K861817. The device is classified under product code KIS. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HORSE BLOOD CELLS IN ALSEVERS CITRATE/DEFIBRINATED?

HORSE BLOOD CELLS IN ALSEVERS CITRATE/DEFIBRINATED is a medical device that received FDA 510(k) clearance on 1986-05-20. The listed applicant is Hazleton Research Products, Inc.. The 510(k) number is K861817.

When did HORSE BLOOD CELLS IN ALSEVERS CITRATE/DEFIBRINATED receive FDA 510(k) clearance?

HORSE BLOOD CELLS IN ALSEVERS CITRATE/DEFIBRINATED received FDA 510(k) clearance on 1986-05-20, under 510(k) number K861817.

Who is the listed applicant for HORSE BLOOD CELLS IN ALSEVERS CITRATE/DEFIBRINATED?

The FDA 510(k) record lists Hazleton Research Products, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HORSE BLOOD CELLS IN ALSEVERS CITRATE/DEFIBRINATED?

The FDA product code for HORSE BLOOD CELLS IN ALSEVERS CITRATE/DEFIBRINATED is KIS.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Hazleton Research Products, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K861997PENICILLIN-STREPTOMYCIN-FUNGIZONE MIXTUREK861996DULBECCO'S MEM WITH 4.5 G/L GLUCOSE MEDIUMK861886DMEM & HAM'S F-12 (1:1) POWDERED MEDIUMK861869GENTAMICIN-50MG/MLK861872ISCOVE'S (MODIFIED) DULBECCO'S MEDIUMK861871NCTC 109 MEDIUM

View all 47 devices →

Related Devices (Code: KIS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K881287ANIMAL AND HUMAN SERACell Culture LaboratoriesK880471BOVINE CALF SERUM SUPPLEMENTED #A-2159Hyclone Laboratories, Inc.K880470BOVINE CALF SERUM CATALOG #A-2119Hyclone Laboratories, Inc.K872847SOLCOSERYL TISSUE CULTURE GROWTH SUPPLEMENTCandace Lane Corp.K870580MLC NORMAL SERUMRjo Biologicals, Inc.K870938FETAL BOVINE SERUMHyclone Laboratories, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑